The novel therapy of the medication represents a major development in the care of diabetes mellitus type 2. Unlike existing drugs, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide182033.bloginwi.com/75871907/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment